version español

Puerto Rico Familial Colorectal Cancer Registry on Facebook

Current Research Studies

Randomized, Double-Blind, Placebo-Controlled Trial of MUC1 Vaccine in Patients with Newly Diagnosed Advanced Adenomas

In this study, we are exploring a new approach to prevention of colon cancer. We are testing a vaccine that we hope could prevent polyps from developing into cancer and prevent polyps from recurring. More information here

Familial Colorectal Cancer Registry

Our long-term objective is the implementation of a population-based familial colorectal cancer registry in Puerto Rico. The primary aim is to learn more about the factors that influence Puerto Rican people to develop CRC. More information here

Curcumin for Polyp Prevention in Patients with Familial Adenomatous Polyposis

This research is being done to find out if the use of curcumin, a natural extract of the plant Curcuma with anti-oxidant and anti-inflammatory properties, can help decrease the number and size of colonic and or duodenal polyps in patients with familial adenomatous polyposis (FAP). More Information here

A Circulating Ligand for Galectin-3 in the Serulm of Individuals with Colorectal Neoplasia

The research study aims to compare the effectiveness of Galectin-3 in blood with the traditional test for occult blood in stools will "(FOBT), to detect pre-cancerous growths, polyps and colorectal cancers. More Information here

Cancer Prevention Network

Cancer Prevention Network

The Cancer Prevention Network (CPN) was founded in 2003 by pioneering physicians from throughout United States and Canada. These physicians saw a need to find novel means of improving quality of life through cancer prevention, particularly for diseases for which treatment still offers a relatively poor prognosis.

In order to bring high-quality cancer research to the communities where patients live and receive most of their medical care, they formed a cancer prevention clinical trials consortium. This consortium allows promising scientific ideas to be tested in many communities throughout CPN. Therefore, there will be numbers of research subjects sufficient to ensure meaningful and powerful research data. CPN seeks healthy adults who are at increased risk for these types of cancer for participation in Phase I and Phase II clinical trials.

Today, CPN has grown to include more than 100 specialists at community clinics and medical centers in 20 states, two Canadian provinces, and the United Kingdom. Its base of research operations is at the Mayo Clinic in Rochester, Minnesota. CPN receives much of its scientific and financial support through the National Cancer Institute's Division of Cancer Prevention. More information here